Skip to content

Animated Storytelling to Promote Colorectal Cancer Screening

Using Short Animated Storytelling to Increase Intent for Colorectal Cancer Screening: A U.S. Online Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07522177
Enrollment
3000
Registered
2026-04-13
Start date
2026-09-01
Completion date
2026-12-01
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Screening

Brief summary

This online randomized controlled trial will evaluate whether a short animated storytelling video increases behavioral expectation to obtain colorectal cancer screening among screening-eligible U.S. adults who report not yet having completed screening. Participants will be recruited via Prolific and randomized in Stanford Qualtrics to view either a brief animated video or a time-neutral informational text. Outcomes will be assessed immediately after exposure.

Interventions

BEHAVIORALShort animated storytelling video

A brief animated storytelling video about colorectal cancer screening and colonoscopy.

Sponsors

Stanford University
Lead SponsorOTHER
Heidelberg University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Resides in the United States * Able to read and understand English * Self-reports not having completed colorectal cancer screening * Provides electronic informed consent

Exclusion criteria

* Prior diagnosis of colorectal cancer * Self-reported completion of colorectal cancer screening

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in behavioral expectation (simple and next-step) to obtain colorectal cancer screening, as measured by a 7-item visual analogue scale.Baseline, immediately post-intervention exposure (up to 24 hours)Participant self-reports their likelihood of discussing, scheduling, or obtaining colorectal cancer screening after exposure to assigned study material. Total scores range from 0-70 with higher scores indicating greater behavioral expectation (Item 7 is reverse scored).

Secondary

MeasureTime frameDescription
Change from baseline in knowledge about colorectal cancer screening and colonoscopy, as measured by a 5-item knowledge questionnaire.Baseline, immediately post-intervention exposure (up to 24 hours)Self-reported knowledge regarding colorectal cancer screening and the preventive role of colonoscopy, including detection and removal of pre-cancerous polyps. Response options are true/false/not sure, with 1 point per correct answer and 0 points for incorrect or "not sure". Total scores range from 0-5, with higher scores indicating higher knowledge.
Change from baseline in perceptions and beliefs about colonoscopy, as measured by a 13-item scale.Baseline, immediately post-intervention exposure (up to 24 hours)Self-reported perceptions an beliefs about colonoscopy include perceived susceptibility, perceived severity, perceived benefits and perceived barriers. Responses will be compared on a Likert scale that ranges from 1-5 (Strongly disagree / Disagree / Neither / Agree / Strongly agree), where higher scores indicate more positive perceptions and beliefs, with the perceived barriers section reverse scored.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMaya Adam, MD, PhD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026